Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ORIFARM GROUP A/S - Group Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   0.5% 0.6% 0.8% 0.8% 0.7% 0.5% 4.4% 4.1%   Credit score (0-100)   99 98 91 92 93 98 47 49   Credit rating   AAA AA AA AA AA AA BBB BBB   Credit limit (mEUR)   21.7 18.6 19.3 22.9 27.0 44.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mEUR)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   982 1,115 1,417 1,513 1,568 1,816 1,816 1,816   Gross profit   151 120 184 231 268 268 0.0 0.0   EBITDA   58.9 52.5 92.1 104 125 119 0.0 0.0   EBIT   47.4 39.9 55.5 58.8 76.0 69.4 0.0 0.0   Pre-tax profit (PTP)   45.4 37.2 37.5 33.8 30.0 18.0 0.0 0.0   Net earnings   34.7 25.5 28.7 25.7 22.4 3.3 0.0 0.0   Pre-tax profit without non-rec. items   45.4 37.2 37.5 33.8 30.0 18.0 0.0 0.0     See the entire income statement 1.0 Balance sheet (mEUR)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   28.7 41.2 110 123 136 136 0.0 0.0   Shareholders equity total   168 149 170 187 208 374 376 376   Interest-bearing liabilities   151 219 630 680 689 549 0.0 0.0   Balance sheet total (assets)   424 494 1,120 1,183 1,230 1,197 376 376   Net Debt   151 219 627 670 687 548 -298 -298     See the entire balance sheet 1.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   982 1,115 1,417 1,513 1,568 1,816 1,816 1,816   Net sales growth   17.8% 13.6% 27.0% 6.8% 3.6% 15.8% 0.0% 0.0%   Gross profit   151 120 184 231 268 268 0.0 0.0   Gross profit growth   15.0% -20.1% 52.5% 25.6% 16.3% -0.3% -100.0% 0.0%   Employees   1,111 1,177 1,955 2,136 2,244 2,259 0 0   Employee growth %   7.2% 5.9% 66.1% 9.3% 5.1% 0.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   424 494 1,120 1,183 1,230 1,197 376 376   Balance sheet change%   23.1% 16.6% 126.8% 5.6% 4.0% -2.7% -68.6% 0.0%   Added value   58.9 52.5 92.1 103.5 120.7 118.9 0.0 0.0   Added value %   6.0% 4.7% 6.5% 6.8% 7.7% 6.5% 0.0% 0.0%   Investments   5 6 69 -35 -38 -54 -160 0   Net sales trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   6.0% 4.7% 6.5% 6.8% 8.0% 6.5% 0.0% 0.0%   EBIT %   4.8% 3.6% 3.9% 3.9% 4.8% 3.8% 0.0% 0.0%   EBIT to gross profit (%)   31.5% 33.1% 30.3% 25.5% 28.3% 26.0% 0.0% 0.0%   Net Earnings %   3.5% 2.3% 2.0% 1.7% 1.4% 0.2% 0.0% 0.0%   Profit before depreciation and extraordinary items %   4.7% 3.4% 4.6% 4.7% 4.6% 2.9% 0.0% 0.0%   Pre tax profit less extraordinaries %   4.6% 3.3% 2.6% 2.2% 1.9% 1.0% 0.0% 0.0%   ROA %   13.7% 10.1% 7.8% 5.1% 6.9% 5.8% 0.0% 0.0%   ROI %   17.6% 13.2% 10.1% 6.6% 8.9% 7.4% 0.0% 0.0%   ROE %   22.9% 16.1% 18.0% 14.4% 11.4% 1.1% 0.0% 0.0%   1.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   39.6% 30.2% 15.1% 15.8% 16.9% 31.3% 100.0% 100.0%   Relative indebtedness %   25.4% 30.1% 62.3% 61.9% 62.4% 42.9% 0.0% 0.0%   Relative net indebtedness %   25.4% 30.1% 62.1% 61.3% 62.2% 42.9% -16.4% -16.4%   Net int. bear. debt to EBITDA, %   255.5% 418.4% 680.9% 647.3% 549.0% 461.0% 0.0% 0.0%   Gearing %   89.7% 147.3% 371.4% 363.2% 331.1% 146.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.2% 4.9% 6.0% 3.8% 7.7% 8.5% 0.0% 0.0%   1.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.5 0.5 0.8 0.8 0.8 0.6 0.0 0.0   Current Ratio   1.4 1.2 1.8 1.8 1.8 1.5 0.0 0.0   Cash and cash equivalent   0.1 0.0 2.8 9.8 2.3 1.0 0.0 0.0   1.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   42.1 44.1 49.9 51.0 49.4 41.7 0.0 0.0   Trade creditors turnover (days)   439.1 319.5 445.5 259.4 272.3 265.6 0.0 0.0   Current assets / Net sales %   31.6% 32.5% 33.0% 35.0% 37.5% 32.0% 16.4% 16.4%   Net working capital   88.9 63.4 213.8 240.5 262.5 206.2 0.0 0.0   Net working capital %   9.1% 5.7% 15.1% 15.9% 16.7% 11.4% 0.0% 0.0%   1.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   1 1 1 1 1 1 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0